Alexion Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put in place, and how Alexion is communicating with patients’ associations and medical community to raise awareness about ultra-rare diseases. …
biotech The founder of this spin-off of the Autonomous University of the State of Morelos focusing on biologicals for human and veterinary use offers an overview of how the company came into life, the lack of culture at Mexican universities of filing patents for academic research and the potential of the…
biotech Bioceres manages investments in agricultural biotechnology and related sciences. The company’s CEO, Federico Trucco, discusses the potential of Argentina’s biotech scene to become a world-class drug developer in biopharma as well as Bioceres’ own investments in the sector. How did you become involved with Bioceres? I have known the…
medical devices The CEO and one of the founders of Lexel explains how the company adapts its medical devices to the specifications required by their international customers. Why did Lexel enter into the medical device market and most important, where did you see the opportunities when creating this company? From the…
See our Cookie Privacy Policy Here
